Enhanced Expression of CD80 (B7-1), CD86 (B7-2), and CD40 and Their Ligands CD28 and CD154 in Fulminant Hepatic Failure
- 30 June 1999
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 154 (6), 1711-1720
- https://doi.org/10.1016/s0002-9440(10)65427-2
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A central role of CD40 ligand in the regulation of CD4+ T-cell responsesImmunology Today, 1996
- The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells.The Journal of Experimental Medicine, 1996
- CD40 Expression by human fibroblastsClinical Immunology and Immunopathology, 1995
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- Exaggerated and persistent cutaneous delayed-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen.JCI Insight, 1994
- Induction of B cell costimulatory function by recombinant murine CD40 ligandEuropean Journal of Immunology, 1994
- CD40 ligand is a T cell growth factorEuropean Journal of Immunology, 1993
- Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.The Journal of Experimental Medicine, 1993
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984